Anti-platelet GPIb monoclonal antibody (HU-12) and activated platelets
Project/Area Number |
23659290
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Laboratory medicine
|
Research Institution | Hirosaki University |
Principal Investigator |
TAKAMI HIDEKI 弘前大学, 保健学研究科, 教授 (10226920)
|
Co-Investigator(Kenkyū-buntansha) |
TAMAI Yoshiko 弘前大学, 医学部附属病院, 講師 (10322934)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | 活性化血小板 / 臨床 |
Research Abstract |
Clinacal usefulness of new monoclonal antibody against human platelet membrane glycoprotein Ib to detect activated platelets was studied. HU-12 was suggested to be a new marker of activated platelets.
|
Report
(4 results)
Research Products
(7 results)